Has Bakshander Kaur, MD received payments from drug or device companies?

Yes. Drug and device makers reported $1,189 in general payments to Bakshander Kaur, MD across 48 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Bakshander Kaur, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Bakshander Kaur, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Bakshander Kaur, MD

Psychiatry · Stockton, CANPI 1477041192

Payments from drug & device makers

$1,189in general payments, 2019–2025

Across 48 payments — averaging $24.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$384
Axsome Therapeutics, Inc.$178
Otsuka America Pharmaceutical, Inc.$138
Neurocrine Biosciences, Inc.$117
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$80
Takeda Pharmaceuticals U.S.A., Inc.$77
plus $214 from 5 others

What the payments were for

Food & beverage$1,189100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie	18	$384
Axsome Therapeutics, Inc.	4	$178
Otsuka America Pharmaceutical, Inc.	2	$138
Neurocrine Biosciences, Inc.	5	$117
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	4	$80
Takeda Pharmaceuticals U.S.A., Inc.	4	$77
Johnson & Johnson	4	$73
Lundbeck LLC	3	$67
Tris Pharma Inc	2	$41
E.r. Squibb & Sons, L.L.C.	1	$20
Supernus Pharmaceuticals, Inc.	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

REXULTI$125
Auvelity$105

How this compares

$1,189 in reported general payments places this provider in the 75th percentile of 4,954 psychiatry providers in California.

See all psychiatry providers in California →

Medicare billing

Part B allowed, 2024

$3,335

Medicare patients

Services billed

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Aripiprazole	30	$10,268
Quetiapine Fumarate	113	$1,942
Bupropion XlBupropion Hcl	62	$1,442
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine	14	$817
Trazodone Hcl	76	$746
Venlafaxine Hcl ErVenlafaxine Hcl	32	$581
Buspirone Hcl	30	$532
Duloxetine Hcl	19	$528
Mirtazapine	26	$437
Hydroxyzine Hcl	20	$398
Lamotrigine	25	$376
Alprazolam	32	$364
Propranolol Hcl	13	$243
Lorazepam	59	$234
Sertraline Hcl	36	$223

Paid to pharmacies, not to this prescriber.

Other psychiatry in Stockton

Elly LeeIrvine$49.8M
Daniel ChuehOrange$17.9M
Eric ChavezSan Diego$15.5M
Lara ShirikjianTorrance$12.6M
John DuffySanta Ana$12M
Marina BusselPlaya Vista$12M
Sherry SoefjeOceanside$11.9M
Steven MacinaHuntington Beach$11.1M
Wakelin McNeelRosemead$11M
Donald AndersonBanning$10.5M

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →